News|Videos|October 9, 2026

Gray Areas: Do Sleep Disorders Actually Drive Neurodegenerative Disease?

Episode 3 of Gray Areas features a conversation with KuangHua Guo, MD, PhD, discussing the evolving debate around whether sleep disorders directly cause neurodegenerative disease and what the current evidence actually shows.

Neurology moves fast, and the assumptions that shape how we practice do not always keep up. Gray Areas is a NeurologyLive series where leading clinicians and researchers challenge widely held beliefs across neurology, unpacking what the evidence actually shows, where it falls short, and where the field still has a lot of figuring out to do.

KuangHua Guo, MD, PhD, assistant professor of neurology and a sleep medicine specialist at the Northwestern University Center for Circadian and Sleep Medicine, joined us to take on a question that has been gaining serious traction in the field: do sleep issues actually cause neurodegenerative disease? Dr. Guo's work focuses on the intersection of sleep, circadian biology, and neurologic disease, making him well positioned to weigh in on a topic where the science is still catching up to the conversation.

In this episode, Guo breaks down where this idea came from, what the evidence does and does not support, what poor sleep could mean for the broader public, and where the research needs to go next.

Timeline

Segment 1: The Myth (1:19 - 5:00) — Dr. Guo unpacks where the conversation around sleep and neurodegeneration began, explaining the feed-forward loop between sleep disruption and neurodegenerative processes and why the relationship is more complex than it appears.

Segment 2: Clinical Implications (5:30 - 8:14) — The downstream impact of poor sleep on patients with neurodegenerative disorders, including striking prevalence data on sleep apnea in this population and why clinicians should have a low threshold for screening.

Segment 3: What We Still Don't Know (9:15 - end) — Dr. Guo outlines the research priorities the field needs to pursue, from better understanding circadian rhythm disruption to the promise of dual orexin antagonists and the importance of early identification tools.


Related to this article